RayzeBio

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.

Domain

rayzebio.com

Employees

51-100

Last Funding

$160.0M

Founded

2017

Frequently Asked Questions

What technologies does RayzeBio use?+

RayzeBio uses 24 technologies including Contact Form 7, Google Analytics, Google Tag Manager.

What industry is RayzeBio in?+

RayzeBio operates in the Biotechnology industry.

Where is RayzeBio based?+

RayzeBio is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026